Particularly, PRMT1 and PRMT6, which catalyze asymmetric dimethylarginine formation, were shown to be significantly up-regulated in lung cancer compared with adjacent normal tissue (1, 2, 16, 17). This evidence concerns the gene PRMT1 and lung carcinoma.